Quick answers
- What is Orapred ODT?
- Orapred ODT is a brand name of Prednisolone, a prescription medicine. The FDA NDC Directory lists 3 Orapred ODT products in 3 strengths and forms.
- Who makes Orapred ODT?
- Advanz Pharma holds the FDA application for Orapred ODT (NDA021959, approved June 1, 2006).
- Is there a generic or store brand of Orapred ODT?
- Yes. The FDA NDC Directory lists 3 other products with the same active ingredients, strength and form as a Orapred ODT product, 3 of them generic. Ask your pharmacist whether one is right for you.
- Has Orapred ODT been recalled?
- No recall linked to Orapred ODT products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Orapred ODT is
Each Orapred ODT product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Prednisolone · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| prednisolone sodium phosphate 10 mg tablet, orally disintegrating (oral) | Orapred ODT | 1 product, 1 company | DailyMed |
| prednisolone sodium phosphate 15 mg tablet, orally disintegrating (oral) | Orapred ODT | 1 product, 1 company | DailyMed |
| prednisolone sodium phosphate 30 mg tablet, orally disintegrating (oral) | Orapred ODT | 1 product, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Prednisolone →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021959 | Advanz Pharma | June 1, 2006 | 3 |
Companies that list Orapred ODT
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Orapred ODT products.
- Advanz Pharma (US) Corp.3 products
Recalls
No recall linked to Orapred ODT products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.